Production (Stage)
Atai Life Sciences N.V.
ATAI
$2.32
$0.1054.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 98.20M | 62.33M | 85.92M | 88.35M | 106.25M |
| Total Receivables | 1.49M | 1.35M | 6.95M | 12.08M | 2.47M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 392.00K | 772.00K | 1.07M | 59.00K | 660.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.89M | 15.68M | 20.13M | 17.43M | 8.13M |
| Total Current Assets | 115.98M | 80.13M | 114.07M | 117.91M | 117.50M |
|
|
|||||
| Total Current Assets | 115.98M | 80.13M | 114.07M | 117.91M | 117.50M |
| Net Property, Plant & Equipment | 5.59M | 3.87M | 1.90M | 1.92M | 2.04M |
| Long-term Investments | 331.00K | 331.00K | -- | -- | -- |
| Goodwill | 331.00K | 331.00K | -- | -- | -- |
| Total Other Intangibles | 3.16M | 3.25M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.60M | 850.00K | 2.43M | 2.43M | 26.57M |
| Total Assets | 195.78M | 159.39M | 197.52M | 215.78M | 269.12M |
|
|
|||||
| Total Accounts Payable | 2.71M | 2.62M | 4.88M | 3.81M | 3.84M |
| Total Accrued Expenses | 7.51M | 9.66M | 11.66M | 12.35M | 9.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.78M | 9.84M | 2.66M | 239.00K | 244.00K |
| Total Finance Division Other Current Liabilities | 3.50M | 2.84M | 439.00K | 1.25M | 1.03M |
| Total Other Current Liabilities | 3.50M | 2.84M | 439.00K | 1.25M | 1.03M |
| Total Current Liabilities | 28.50M | 24.95M | 19.64M | 17.64M | 15.01M |
|
|
|||||
| Total Current Liabilities | 28.50M | 24.95M | 19.64M | 17.64M | 15.01M |
| Long-Term Debt | 11.60M | 16.33M | 22.74M | 20.86M | 21.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.59M | 732.00K | 808.00K | 838.00K | 907.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 821.00K | 817.00K | 8.02M | 7.91M | 7.99M |
| Total Liabilities | 43.51M | 42.83M | 51.20M | 47.25M | 45.86M |
|
|
|||||
| Common Stock & APIC | 897.84M | 834.97M | 827.13M | 822.02M | 819.12M |
| Retained Earnings | -726.64M | -700.21M | -661.25M | -634.96M | -577.65M |
| Treasury Stock & Other | -19.15M | -18.47M | -20.16M | -19.17M | -18.93M |
| Total Common Equity | 152.05M | 116.30M | 145.72M | 167.89M | 222.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 152.05M | 116.30M | 145.72M | 167.89M | 222.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 221.00K | 257.00K | 596.00K | 643.00K | 713.00K |
| Total Equity | 152.27M | 116.55M | 146.32M | 168.53M | 223.26M |
|
|
|||||